中文 | English
Return
Total: 415 , 1/42
Show Home Prev Next End page: GO
Author:( Qingqing WANG)

1.Preparation and Study of Monoclonal Antibodies to Human Lung Cancers

Qingqing WANG

Journal of Kunming Medical University 1988;0(03):-

2.Changes of levels of CD4+CD25+Foxp3+regulatory T cells in HDCP peripheral blood and its significance

Yidong ZHANG ; Qingqing WANG

Chinese Journal of Immunology 2015;(9):1253-1256

3.Research advances in effects of general anesthetics on central nervous system of pediatric patients and immature animals

Qingqing ZHANG ; Yingwei WANG

Journal of Shanghai Jiaotong University(medical Science) 2010;30(2):233-235

4.Primary angiitis of the central nervous system

Qingqing WANG ; Xiaokun QI

Chinese Journal of Neurology 2021;54(4):392-398

5.Effect of patients with anxiety and depression in elderly patients with hypertension antihypertensive effect of psychological intervention combined with Flupentixol and Melitracen Tablets

Qingqing SUN ; Wei WANG ; Lihua WANG

Chinese Journal of Biochemical Pharmaceutics 2017;37(7):280-281

6.Advance in the study of targeting delivery system for siRNA mediated by aptamers.

Xiaolin WANG ; Qingqing WANG ; Haifeng SONG

Acta Pharmaceutica Sinica 2012;47(7):850-5

7.Research progress into Castleman disease

Qingqing CHEN ; Huilai ZHANG ; Huaqing WANG

Chinese Journal of Clinical Oncology 2014;(17):1135-1139

8.Effects of polyethylene glycol on seed germination of Cassia occidentalis

Jiaqing HE ; Xing WANG ; Qingqing YAO

Chinese Traditional and Herbal Drugs 1994;0(09):-

9.Cognitive Dysfunction in Vascular Dementia

Chunxue WANG ; Jie LONG ; Qingqing LU

Chinese Mental Health Journal 1991;0(05):-

10.A long-term follow-up study on the treatment of small cell lung cancer using teniposide/carboplatin with etoposide/carboplatin as first-line therapy

Qingqing CHEN ; Huilai ZHANG ; Huaqing WANG

Tianjin Medical Journal 2015;(7):788-791

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 415 , 1/42 Show Home Prev Next End page: GO